Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute

Updated 06/21/2024

Status Not yet recruiting

Clinical Trial Summary

The aim of the study is to investigate the effect of an SGLT-2 inhibitor on postoperative hyperglycemia after acute abdominal surgery in patients without diabetes

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05314725
Study type	Interventional
Source	Zealand University Hospital
Contact	Emilie Palmgren Colov, MD
Phone	+45 61335122
Email	eco@regionsjaelland.dk
Status	Not yet recruiting
Phase	Phase 2
Start date	June 1, 2022
Completion date	June 1, 2023

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT02946411` - Correlation of Hospital Stay Length With the Glucose Levels After Cardiac Surgery
	Completed	`NCT04408768` - Stress Hyperglycemia and Acute Ischemic Stroke
	Terminated	`NCT03743025` - Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients	Phase 4
	Completed	`NCT02726958` - Early Postoperative Blood Glucose Variability and Outcome After TAVI	N/A
	Completed	`NCT01969149` - Exenatide for Stress Hyperglycemia	Phase 2/Phase 3
	Terminated	`NCT02068989` - Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus	N/A
	Completed	`NCT02847104` - Medical ICU Paper-based Dynamic Insulin Protocol	N/A
	Not yet recruiting	`NCT01776476` - A Randomized Controlled Trial of Glutamine Dipeptide in Severe Trauma	Phase 2
	Recruiting	`NCT02180555` - Diabetes Mellitus After Intensive Care Admission	N/A
	Not yet recruiting	`NCT04591561` - Incidence and Course of Stress Hyperglycemia in Critically Ill Children Admitted to PICU of Assiut University Children Hospital